Correlation Between ArriVent BioPharma, and WiMi Hologram

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ArriVent BioPharma, and WiMi Hologram at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ArriVent BioPharma, and WiMi Hologram into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ArriVent BioPharma, Common and WiMi Hologram Cloud, you can compare the effects of market volatilities on ArriVent BioPharma, and WiMi Hologram and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ArriVent BioPharma, with a short position of WiMi Hologram. Check out your portfolio center. Please also check ongoing floating volatility patterns of ArriVent BioPharma, and WiMi Hologram.

Diversification Opportunities for ArriVent BioPharma, and WiMi Hologram

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ArriVent and WiMi is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ArriVent BioPharma, Common and WiMi Hologram Cloud in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WiMi Hologram Cloud and ArriVent BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ArriVent BioPharma, Common are associated (or correlated) with WiMi Hologram. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WiMi Hologram Cloud has no effect on the direction of ArriVent BioPharma, i.e., ArriVent BioPharma, and WiMi Hologram go up and down completely randomly.

Pair Corralation between ArriVent BioPharma, and WiMi Hologram

Given the investment horizon of 90 days ArriVent BioPharma, Common is expected to under-perform the WiMi Hologram. But the stock apears to be less risky and, when comparing its historical volatility, ArriVent BioPharma, Common is 3.4 times less risky than WiMi Hologram. The stock trades about -0.26 of its potential returns per unit of risk. The WiMi Hologram Cloud is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  100.00  in WiMi Hologram Cloud on November 29, 2024 and sell it today you would lose (20.00) from holding WiMi Hologram Cloud or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ArriVent BioPharma, Common  vs.  WiMi Hologram Cloud

 Performance 
       Timeline  
ArriVent BioPharma, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ArriVent BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
WiMi Hologram Cloud 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in WiMi Hologram Cloud are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak primary indicators, WiMi Hologram demonstrated solid returns over the last few months and may actually be approaching a breakup point.

ArriVent BioPharma, and WiMi Hologram Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ArriVent BioPharma, and WiMi Hologram

The main advantage of trading using opposite ArriVent BioPharma, and WiMi Hologram positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ArriVent BioPharma, position performs unexpectedly, WiMi Hologram can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WiMi Hologram will offset losses from the drop in WiMi Hologram's long position.
The idea behind ArriVent BioPharma, Common and WiMi Hologram Cloud pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device